Co-creating ethical horizons: Public attitudes and regulatory considerations for future cancer nanomedicines in clinical trials

The advancement of future cancer nanomedicines, like collective nanosystems, offers a chance to promote responsible governance by anticipating technological developments and addressing ethical issues. Collective nanosystems are large numbers of tiny nano-sized carriers that work together to find and remove cancer cells, drawing inspiration from teams of cooperative robots. Computer models and artificial intelligence can be used to enhance collective nanosystem design, aiming to accelerate targeted treatments and streamline drug development by reducing experimental time.

Groundbreaking study shows that dogs can smell cancer in other dogs

The results of a study into whether cancer detection dogs can smell bladder cancer in other dogs’ urine suggests that this could be an effective new way to diagnose the disease in dogs. The research, involving University of Bristol researchers, is published in Veterinary and Comparative Oncology.

Bristol researchers contribute to House of Lords report on obesity and diet

"The Government needs a plan to fix our broken food system and turn the tide on the obesity public health emergency, says Lords committee.". This is the key conclusion reached by the House of Lords Food, Diet and Obesity Committee in a report published today. The report, ‘Recipe for health: a plan to fix our broken food system’, finds that obesity and diet-related disease are a public health emergency that costs society billions each year in healthcare costs and lost productivity.

Three University of Bristol projects awarded European Research Council Consolidator Grants

A total of more than £5 million of funding has been awarded to three University of Bristol projects through the European Research Council (ERC) Consolidator Grants announced today (Tuesday 3 December 2024).

A new way forward for patients with a brain tumour

A new landmark report, led by the University of Bristol researchers, highlights that access to genomic testing for patients with a brain tumour, is inequitable: it is estimated that fewer than 5 per cent of eligible adult patients with a brain tumour are accessing certain tests.

Pioneering report exposes worsening health threats of climate change in UK

A new report has revealed for the first time the wide-ranging and increasing health dangers posed by long-term weather extremes in the UK, as the effects of climate change deepen.

ProtecT trial receives award for pioneering research demonstrating the safety of active surveillance

A study to find out the best ways of treating prostate cancer has been named the 2024 recipient of the Active Surveillance Patients International (ASPI) Special Award. The ProtecT trial, led by the Universities of Bristol and Oxford, received the award for game-changing research in the development of the active surveillance approach to managing low-risk prostate cancer. Their research has proved active monitoring in patients with lower-risk prostate cancer was as safe as aggressive treatments.

AI ‘hallucinations’ tackled by University of Bristol researchers

Significant strides in addressing the issue of AI 'hallucinations' and improving the reliability of anomaly detection algorithms in Critical National Infrastructures (CNI) have been made by scientists based in the University's of Bristol’s School of Computer Science.

New films set to boost effective adoption of Health Impact Assessments

Expert voices from planning, health, government and consultants have shared their insights of using Health Impact Assessments as a force for good to create healthier new communities.

From the canine world to exploring human immunology

New research could give hope to patients with blood disorders such as leukaemia, thanks to a £1.7 million grant from Cancer Research UK.

Majority of female cancer survivors at low risk of developing most obstetric complications

The majority of women who have survived a cancer diagnosed age 15-39 are at low risk of obstetric complications, a new study has found.

The Bristol Cancer Research Network's Early Career Researchers' symposium 2024

The University of Bristol's Cancer Research Network hosted its third annual symposium dedicated to early career researchers on 18 June 2024. The event showcased the extraordinary and diverse research in cancer being conducted across Bristol and the South-West.

Bristol Professor joins Academy of Medical Sciences Fellowship

Two Bristol academics, Professors Eugenia Piddini and Gene Feder OBE, have been elected to the Academy of Medical Sciences’ respected and influential Fellowship. They join 58 exceptional biomedical and health scientists selected for their exceptional contributions to the advancement of medical science.

Bristol spin-out Dynamic Therapeutics wins prestigious Blavatnik Prize for U-RHYTHM technology

Dynamic Therapeutics, a University of Bristol spin-out, has today [25 April] been awarded a prestigious Blavatnik Prize by QantX, a leading venture capital firm, for its pioneering U-RHYTHM technology. The award recognises the scientific advances and future potential of the UK's most innovative scientists and engineers.

Students tackle gap in black and brown skin cancer diagnosis

Three medical students are solving the shocking disparity in skin cancer care between those with dark skin and those with white skin.

Screening with a PSA test has a small impact on prostate cancer deaths but leads to overdiagnosis

The largest study to date investigating a single invitation to a PSA blood test to screen for prostate cancer has found it had a small impact on reducing deaths, but also led to overdiagnosis and missed early detection of some aggressive cancers. The CAP trial, published in the Journal of the American Medical Association (JAMA) and carried out by researchers from the universities of Bristol, Oxford and Cambridge, involved over 400,000 men aged 50-69. Just under half received a single invitation for a PSA test as part of the trial.

University of Bristol and UCL to lead support hub for UK's longitudinal population studies

The University of Bristol and UCL will lead the Population Research UK (PRUK) co-ordination hub, part of an existing strategic investment from the UKRI Infrastructure Fund.

Patient recovery after surgery for oesophageal cancer isn’t influenced by using standard or keyhole incisions

New research has found no evidence of a difference between recovery time and complications when comparing standard and keyhole surgical incisions for the treatment of oesophageal cancer (cancer of the gullet). The study, led by the University of Bristol Medical School and published in the British Journal of Surgery, showed surgeons treating patients with oesophageal cancer do not need to change their practice if they have a strong preference for either procedure type.

New cancer and domestic abuse toolkit launched

A new toolkit to support cancer professionals to identify and respond to signs of domestic abuse in patients with cancer and their carers is being launched today [26 March]. The toolkit has been developed in partnership with the University of Bristol, Standing Together Against Domestic Abuse, and Macmillan Cancer Support.

Bristol leaps ahead in training next generation of leaders to tackle major global challenges

Hundreds of talented scientists and engineers are set to advance solutions for some of the world’s most pressing challenges, ranging from reaching net-zero and developing sustainable energy to improving digital security and making the latest health breakthroughs.

New Digital Health Hub launches in South West England and Wales

A consortium of universities from across the South West of England and Wales have come together to form a brand new Digital Health Hub which will elevate the region’s digital health capability through leadership, engagement, acceleration and partnership (LEAP).

Anti-diabetic drugs could lower risk of primary and secondary brain cancer

Diabetic patients who take anti-diabetic drugs - known as glitazones – long term had a lower risk of primary and secondary brain cancer compared with diabetic patients on other medications, new research led by the University of Bristol has found.

Fakes, facts, society and health

The Elizabeth Blackwell Institute for Health Research welcomed Patricia Kingori, Professor of Global Health Ethics at the University of Oxford, as their 10th Annual Public Lecture speaker.

Nurturing Equality, Diversity and Inclusion - Supporting Research Careers in Health and Biomedicine

Bristol scientists supercharge Artificial Intelligence in revolutionary £80 million national initiative

Experts are helping put the UK at the forefront of AI advances, using it to transform current uses and tackle important global challenges.

Weight loss intervention in people with type 2 diabetes influences cancer-associated proteins

A weight loss intervention in people with type 2 diabetes was found to alter levels of cancer-related proteins, according to the findings of a new University of Bristol-led study. The study is the first to show that weight loss in people recently diagnosed with diabetes can change the levels of cancer-related chemicals circulating in the blood.

University of Bristol stem cell spinout secures £7.6m seed funding

CellVoyant, an AI-first biotechnology spin-out from the University of Bristol accelerating the development of new stem cell therapies, has announced a £7.6 million seed round.

Wellcome Trust Awards £3.1 Million to Bristol Researcher for Stem Cell Biology Research

Dr. Bethan Lloyd-Lewis, a Vice-Chancellor’s Research Fellow at the School of Cellular and Molecular Medicine (CMM), has been awarded a £3.1 million fellowship from the Wellcome Trust to lead research into the regulatory mechanisms influencing stem cell fate decisions during organ development and cancer.